RISE is the innovation arm of Assuta – Israel’s leading private chain of hospitals. RISE already partners with 30 Israeli startups and has just added five more. Ibex Medical, Senseera, Theator, Magentiq Eye and MaveriQx – the only startup not … Continue reading →

Roche has entered an agreement with Israel’s Ibex Medical Analytics to jointly develop an embedded image analysis workflow. It will allow pathologists to check biopsies using Roche’s NAVIFY & uPath software while seamlessly accessing Ibex’s AI algorithms, insights, and tools. … Continue reading →

Israel’s Ibex Medical Analytics (see here previously) was a bronze winner in the Diagnostic Technologies category at the 2024 Edison Awards. Ibex won the award for its Galen Breast HER2 platform, that identifies the protein responsible for the proliferation of … Continue reading →

Israel’s Ibex Medical has expanded its partnership with France’s Medipath (see here previously) to cover cancer analysis of multiple tissue types at more of Medipath’s 30 labs. Medipath provides pathology services to 250+ hospitals and clinics across France. https://ibex-ai.com/medipath-ai-expansion/

Israel’s Ibex Medical Analytics (see here previously) has launched a new cancer detection platform – Galen 3.0 with improved AI algorithms to detect cancer in prostate, breast and gastric biopsies. It also calculates the aggressiveness of prostate cancer, reducing time … Continue reading →

Israel’s Ibex Medical (see here previously) has received the CE Mark for its Galen Gastric system, to detect gastrointestinal cancer – one of the most common malignant diseases worldwide, with over a million new cases every year and relatively poor … Continue reading →

Israel’s Ibex Medical (see here previously) has launched its new Galen Gastric system, to detect gastrointestinal cancer, at Israel’s Maccabi HMO (Health Management organization). Maccabi is the world’s only health system to use AI for multi-tissue detection (breast, prostate and … Continue reading →

Alverno Laboratories, one of the largest integrated laboratory networks in the United States, is to deploy the Galen AI platform from Israel’s Ibex Medical Analytics (see here previously) to help pathologists provide accurate cancer diagnosis for patients. https://www.calcalistech.com/ctech/articles/0,7340,L-3914741,00.html

Unilabs, one of Europe’s largest diagnostics companies, is to implement the AI-based cancer diagnostic software from Israel’s Ibex Medical Analytics (see here previously). The initial rollout will begin in Sweden and then continue to 16 more European countries. https://www.timesofisrael.com/swiss-diagnostic-firm-unilabs-to-use-ibex-cancer-detecting-tech-in-labs/

Having just received European CE mark certification for its Galen AI cancer diagnostic software (see here), Israel’s Ibex Medical has now been awarded “Breakthrough” designation by the US FDA. This will help fast-track clinical review and regulatory approval of its … Continue reading →